Double-Duty attack on arthritis: can two drugs beat one?

NCT ID NCT04870203

Summary

This study is for people with rheumatoid arthritis (RA) who haven't gotten enough relief from their current biologic or targeted drugs. It's testing if taking two powerful medications together—baricitinib and an anti-TNF drug—works better to control the disease than taking just baricitinib alone. About 160 participants will be randomly assigned to one of these two treatment groups to compare their effectiveness and safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AP-HM - service de rhumatologie

    Marseille, France

  • AP-HP - Hopital Avicenne - service de rhumatologie

    Bobigny, France

  • AP-HP - Hôpital Bichat - service de rhumatologie

    Paris, France

  • AP-HP - Hôpital Cochin - service de rhumatologie

    Paris, France

  • AP-HP - Hôpital Kremlin-Bicêtre - service de rhumatologie

    Le Kremlin-Bicêtre, France

  • AP-HP - Hôpital La Pitié-Salpetrière - service de rhumatologie

    Paris, France

  • AP-HP - Hôpital Saint-Antoine - service de rhumatologie

    Paris, France

  • CH Emile Roux - service rhumatologie

    Le Puy-en-Velay, France

  • CH de Belfort - service de rhumatologie

    Belfort, France

  • CH de Dax - service de rhumatologie

    Dax, France

  • CH de Niort - service de rhumatologie

    Niort, France

  • CH de Pau - service de rhumatologie

    Pau, France

  • CH de Reims - service de rhumatologie

    Reims, France

  • CH de Saint-Malo - service de rhumatologie

    St-Malo, France

  • CH de la Côte Basque - service de rhumatologie

    Bayonne, France

  • CH du Mans - service de rhumatologie

    Le Mans, France

  • CHD VENDEE - service de rhumatologie

    La Roche-sur-Yon, France

  • CHRU de Nancy - service de rhumatologie

    Vandœuvre-lès-Nancy, France

  • CHRU de Strasbourg - service de rhumatologie

    Strasbourg, France

  • CHRU du Tours - service de rhumtologie

    Tours, France

  • CHU de Bordeaux - service de rhumatologie

    Bordeaux, France

  • CHU de Brest - Service de rhumatologie

    Brest, France

  • CHU de Clermont-Ferrand - service de rhumatologie

    Clermont-Ferrand, France

  • CHU de Montpellier - service de rhumatologie

    Montpellier, France

  • CHU de Nice - service de rhumatologie

    Nice, France

  • CHU de Nîmes - service de rhumatologie

    Nîmes, France

  • CHU de Saint-Etienne- service de rhumatologie

    Saint-Etienne, France

  • CHU de Toulouse - service de rhumatologie

    Toulouse, France

  • Clinique de l'Infirmerie - service de rhumatologie

    Caluire-et-Cuire, France

  • Groupement des Hôpitaux de l'Institut Catholique de Lille - service de rhumatologie

    Lomme, France

  • Hopital NOVO - service de rhumatologie

    Pontoise, France

  • Hospices Civils de Lyon - service de rhumatologie

    Pierre-Bénite, France

  • Hôpital Saint-Joseph - service de rhumatologie

    Marseille, France

  • Nouvel Hôpital Orléans La Source - service de rhumatologie

    Orléans, France

  • Polyclinique de Limoges - service de rhumatologie

    Limoges, France

  • service de Rhumatologie - CH Princesse Grace

    Monaco, Monaco

Conditions

Explore the condition pages connected to this study.